168 related articles for article (PubMed ID: 20723255)
1. Human protein C concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients.
Veldman A; Fischer D; Wong FY; Kreuz W; Sasse M; Eberspächer B; Mansmann U; Schosser R
Crit Care; 2010; 14(4):R156. PubMed ID: 20723255
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency.
Manco-Johnson MJ; Bomgaars L; Palascak J; Shapiro A; Geil J; Fritsch S; Pavlova BG; Gelmont D
Thromb Haemost; 2016 Jul; 116(1):58-68. PubMed ID: 27052576
[TBL] [Abstract][Full Text] [Related]
3. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
[TBL] [Abstract][Full Text] [Related]
4. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
Schellongowski P; Bauer E; Holzinger U; Staudinger T; Frass M; Laczika K; Locker GJ; Quehenberger P; Rabitsch W; Schenk P; Knöbl P
Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
[TBL] [Abstract][Full Text] [Related]
5. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
[TBL] [Abstract][Full Text] [Related]
6. Paediatric presentation and outcome of congenital protein C deficiency in Japan.
Ohga S; Kang D; Kinjo T; Ochiai M; Doi T; Ishimura M; Kayamori Y; Urata M; Yamamoto J; Suenobu SI; Kanegane H; Ikenoue T; Shirahata A; Hara T
Haemophilia; 2013 May; 19(3):378-84. PubMed ID: 23379934
[TBL] [Abstract][Full Text] [Related]
7. Protein C substitution in sepsis-associated purpura fulminans.
Rintala E; Kauppila M; Seppälä OP; Voipio-Pulkki LM; Pettilä V; Rasi V; Kotilainen P
Crit Care Med; 2000 Jul; 28(7):2373-8. PubMed ID: 10921567
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic features of Chinese pediatric patients with severe congenital protein C deficiency who first presented with purpura fulminans: A case series study and literature review.
Tang X; Zhang Z; Yang H; Xiao J; Wen X; Dou Y; Yu J; Hu Y
Thromb Res; 2022 Feb; 210():70-77. PubMed ID: 35026611
[TBL] [Abstract][Full Text] [Related]
9. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.
White B; Livingstone W; Murphy C; Hodgson A; Rafferty M; Smith OP
Blood; 2000 Dec; 96(12):3719-24. PubMed ID: 11090052
[TBL] [Abstract][Full Text] [Related]
10. New plasma protein C and protein S concentrate: A synergy for therapeutic purposes.
Mori F; Angelini C; Farina C
Vox Sang; 2024 Mar; 119(3):193-202. PubMed ID: 38018260
[TBL] [Abstract][Full Text] [Related]
11. Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.
Barton P; Kalil AC; Nadel S; Goldstein B; Okhuysen-Cawley R; Brilli RJ; Takano JS; Martin LD; Quint P; Yeh TS; Dalton HJ; Gessouron MR; Brown KE; Betts H; Levin M; Macias WL; Small DS; Wyss VL; Bates BM; Utterback BG; Giroir BP
Pediatrics; 2004 Jan; 113(1 Pt 1):7-17. PubMed ID: 14702440
[TBL] [Abstract][Full Text] [Related]
12. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans.
Smith OP; White B; Vaughan D; Rafferty M; Claffey L; Lyons B; Casey W
Lancet; 1997 Nov; 350(9091):1590-3. PubMed ID: 9393338
[TBL] [Abstract][Full Text] [Related]
13. Treatment of purpura fulminans in meningococcemia with protein C concentrate.
Rivard GE; David M; Farrell C; Schwarz HP
J Pediatr; 1995 Apr; 126(4):646-52. PubMed ID: 7699550
[TBL] [Abstract][Full Text] [Related]
14. Skin Necrosis and Purpura Fulminans in Children With and Without Thrombophilia--A Tertiary Center's Experience.
Fruchtman Y; Strauss T; Rubinstein M; Ben Harush M; Revel-Vilk S; Kapelushmik J; Paret G; Kenet G
Pediatr Hematol Oncol; 2015; 32(7):505-10. PubMed ID: 26436558
[TBL] [Abstract][Full Text] [Related]
15. Human protein C concentrates for replacement therapy in congenital and acquired protein C deficiency.
Knoebl PN
Drugs Today (Barc); 2008 Jun; 44(6):429-41. PubMed ID: 18596997
[TBL] [Abstract][Full Text] [Related]
16. Long-term subcutaneous protein C replacement in neonatal severe protein C deficiency.
de Kort EH; Vrancken SL; van Heijst AF; Binkhorst M; Cuppen MP; Brons PP
Pediatrics; 2011 May; 127(5):e1338-42. PubMed ID: 21482600
[TBL] [Abstract][Full Text] [Related]
17. Purpura fulminans: recognition, diagnosis and management.
Chalmers E; Cooper P; Forman K; Grimley C; Khair K; Minford A; Morgan M; Mumford AD
Arch Dis Child; 2011 Nov; 96(11):1066-71. PubMed ID: 21233082
[TBL] [Abstract][Full Text] [Related]
18. Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis.
Colling ME; Bendapudi PK
Transfus Med Rev; 2018 Apr; 32(2):69-76. PubMed ID: 29157918
[TBL] [Abstract][Full Text] [Related]
19. [Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis].
Pettenazzo A; Malusa T
Minerva Anestesiol; 2004 May; 70(5):357-63. PubMed ID: 15181416
[TBL] [Abstract][Full Text] [Related]
20. Use of protein C concentrate in neonatal period.
De Carolis MP
Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):29-30. PubMed ID: 21089715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
